Lorillard
Physical, Chemical, and Biological Properties of Tobacco, Cigarette Smoke, and Other Tobacco Products
Fields
- Author
- Huber, G.L.
- Alias
- 87655436/87655471
- Type
- SCRT, SCIENTIFIC REPORT
- BIBL, BIBLIOGRAPHY
- FOOT, FOOTNOTE
- BIBL, BIBLIOGRAPHY
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STORAGE
- Site
- G65
- Named Organization
- Clinical Epidemiology Branch
- Division of Cancer Prevention + Control
- Epa, Environmental Protection Agency
- Ftc, Federal Trade Commission
- Leipzig Pathological Inst
- NCI, Natl Cancer Inst
- Royal College of Physicians London
- Twg, Tobacco Working Group
- Usda, U.S. Dept of Agriculture
- Biometry Branch
- Division of Cancer Prevention + Control
- Named Person
- Belt
- Brockie
- Craig, T.
- Garcia
- Griffith
- Hart, J.P.
- Hecht
- Hoffmann
- Horace, M.
- Huber, M.
- Idell
- Jones, S.
- Phillips, J.
- Sommering
- Surgeon General
- Brockie
- Date Loaded
- 12 Feb 1999
- Master ID
- 87653565/6821
Related Documents:- 87653565
- 87653567
- 87653568 Washington Legal Foundation Represents Bipartisan Congressional Group Before Epa
- 87653569-3583 Comments of the Washington Legal Foundation, and U.S. Representatives Walter Jones, Steve Neal, Howard Coble, Bill Hefner, Butler Derrick, Robin Tallon, Charles Hatcher, Tom Bliley, John Tanner, Alex Mcmillan, Bart Gordon and Hal Rogers Concerning the Environmental Protection Agency's Draft 'guide to Workplace Smoking Policies'
- 87653584-3661 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87653662-3937 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87653938-3939 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of the Tobacco Industry
- 87653941-3999 United States Environmental Protection Agency Comments of the Tobacco Institute on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Review Draft
- 87654000-4002 Exhibit A Environmental Tobacco Smoke: A Handbook for Assessment, Mitigation, and Prevention of Exposures
- 87654004-4100 Comments of R.J. Reynolds Tobacco Company on Health Effects of Passive Smoking - Assessment of Lung Cancer in Adults and Respiratory Disorders in Children ( Epa/600/6-90/0064 - External Review Draft)
- 87654101-4139 A Statistical Review of the Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa/600/6-90/00064 - External Review Draft)
- 87654140-4165 RJR Appendix B Comments of the R.J. Reynolds Tobacco Company on Appendix C to the Health Assessment - Dosimetry of Environmental Tobacco Smoke
- 87654166-4174 RJR Appendix C Comments of the R.J. Reynolds Tobacco Company on Appendix D to the Health Assessment - Alternative Approaches for Estimating the Yearly Number of Lung Cancer Deaths in Nonsmokers Due to Ets Based on Dose Response Modeling
- 87654175-4289 the Epa Review Draft: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87654290-4312 the Epa Review Draft: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87654313-4314 United States Environmental Protection Agency Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies Public Review Draft Comments of the Tobacco Industry
- 87654315 A
- 87654316-4386 United States Environmental Protection Agency Comments of the Tobacco Institute on Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654387-4406 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Tobacco Institute Substitute Text)
- 87654408-4418 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies U.S. E.P.A. Public Review Draft Comments of Phillip Morris Inc.
- 87654419 C
- 87654420-4485 Before the United States Environmental Protection Agency Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies Epa/400/6-90/004 Response of R.J. Reynolds Tobacco Company
- 87654489-4496 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Differences Between Mainstream and Sidestream Smoke
- 87654497-4502 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1 : What Is Ets? Table (Page 10): 'toxic and Cancer Causing Agents in Mainstream and Sidestream Cigarette Smoke' Topic: Nitrosoamines
- 87654503-4514 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Chapter 2: Measuring Ets in the Air and Body Section: Assessing Ets Exposure Section: Biomarker Studies
- 87654515-4531 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa /400/6-90/004 5: Reducing Exposure to Ets
- 87654532-4540 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Chapter 1: What Is Ets? Section: Hazardous Constituents in Ets
- 87654541-4547 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Differences Between Mainstream and Sidestream Smoke Section: Chemical Make-Up Section: Other Contaminants
- 87654548-4572 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Other Surrogates Topic: Benzene
- 87654573-4578 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Chapter 3: Health Effects of Ets Section: Irritation
- 87654579-4589 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Topic: Hcn
- 87654592-4603 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Topic: Carbon Monoxide (Co) Chapter 3: Health Effects of Ets Section: People with Heart Disease Section: Heart Disease Section: Respiratory Disease
- 87654604-4612 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Measuring Ets in the Air and Body Topic: Diffusion
- 87654613-4618 Comments on Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Chapter 1: What Is Ets? Toxins and Irritants Carbon Monoxide (Co)
- 87654619-4645 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Assessing Ets Exposure Section: Air Monitoring Studies
- 87654646-4652 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Table (Page 10): 'toxic and Cancer Causing Agents in Mainstream and Sidestream Cigarette Smoke'
- 87654653-4658 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Mathematical Models
- 87654662-4671 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 3: Health Effects of Ets Section: Cancer at Other Sites
- 87654676-4678 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654680-4688 Comments on the Draft Epa Document Environmental Tobacco Smoke A Guide to Workplace Smoking Policies
- 87654690
- 87654691-4722 Acute Effect of Passive Smoking on Lung Function and Airway Responsiveness in Asthmatic Children
- 87654724-4729 Comments of Jack E. Peterson, P.E., C.I.H., Ph.D. On Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654731-4751 Critique of the Draft Report Entitled Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654753-4763 A Critique of the Public Review Draft 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies' Issued by the Indoor Air Division of the Office of Air and Radiation, U.S. Environmental Protection Agency
- 87654765-4771 Commentary: 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies,' Epa Public Review Draft
- 87654773-4775
- 87654777-4850 Comments on the Draft Report by the U.S. Environmental Protection Agency 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies'
- 87654852-4865 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies: Comments
- 87654866A-4877 Comments by Philip Witorsch, M.D., Facp, Fccp, on Epa Draft Document 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies'
- 87654878-4880 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume I
- 87654882-4909 Non - Epidemiologic Studies on Potential Pulmonary Carcinogen in Environmental Tobacco Smoke: A Critique of the Environmental Protection Agency's Designation of Environmental Tobacco Smoke As A Group A Carcinogen Pulmonary Carcinogens in Ets (900925)
- 87654911-4915 Comments on Epa Review Drafts 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children.' and 'environmental Tobacco Smoke: A Guide to Workplace Smoking Polices'.
- 87654917-4921 Comment on the External Review Draft of Epa's 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87654923-4942 Review of: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Review Draft: 900500) Office of Research and Development & Office of Air and Radiation U.S. Environmental Protection Agency
- 87654944-4948 Epa Draft on Environmental Tobacco Smoke E.T.S.
- 87654950-4963 'the Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children,' Review Draft Epa 900500 Statement of John Wesley Clayton, Jr., Ph.D., D.A.T.S.
- 87654965-4988 Comments on the Risk Assessment Portion of the 900500 Epa Draft Report Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87654990-5007 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children A Commentary on Issues Relating to Lung Cancer in the 900000 Epa External Draft Review
- 87654997-5002 Comments on the Possible Relation Between Passive Smoking and Lung Cancer Appendix Number 1
- 87655009-5011 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' Epa/600/6-90/006a: 900500 Review Draft
- 87655013-5028 Review Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Epa 600/6-90/006a
- 87655030-5032
- 87655033-5036 the Role of Histopathology in the Evaluation of Risk of Lung Cancer From Environmental Tobacco Smoke
- 87655038-5043 Comments on Epa External Review Draft Report, 900517: Health Effects of Passive Smoking: Assessment of Lung Cancer and Respiratory Disorders in Children (Epa / 600/6-90/006a).
- 87655045-5070 Comments on the Review Draft Released by the Environmental Protection Agency Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655072-5080 Critique of Draft Epa Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655081-5122 Meta-Analysis in Epidemiology, with Special Reference to Studies of the Association Between Exposure to Environmental Tobacco Smoke and Lung Cancer: A Critique
- 87655127-5132
- 87655134-5140
- 87655142-5162 Assessing Exposures to Environmental Tobacco Smoke As It Pertains to: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655164-5194 A Comment on 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'. Epa / 600/6-90/006a, 900500
- 87655196-5201 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children.' A Commentary on Specific Issues Raised in the Epa 900500 External Review Draft
- 87655203-5215 Comments by Alan J. Gross, Ph.D. On Chapters 3 and 4 of the Epa Draft Document: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87655217-5254 Comments in Regard to: Draft Epa Documents Entitled (1) 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' (2) Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87655256-5643 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume II
- 87655259 22
- 87655260-5321 Comments on the Draft Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655322 23
- 87655323-5326
- 87655327-5404 Commentary on Epa Review Draft 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655405 Appendix A Curriculum Vitae of Commentator
- 87655406 Appendix C Health Effects of Involuntary Smoking: Impact on Tobacco Use, Smoking Cessation, and Public Policies. Seminars in Respiratory Medicine 11 (1) : 87-114. 900000
- 87655407-5434 Health Effects of Involuntary Smoking: Impact on Tobacco Use, Smoking Cessation, and Public Policies
- 87655435 Appendix D Physical, Chemical, and Biological Properties of Tobacco, Tobacco Cigarette Smoke, and Other Tobacco Products Seminars in Respiratory Medicine 10 (4): 297-332, 890000
- 87655472 Appendix E the Negative Study Problem
- 87655473 A Perspective on Negative Studies
- 87655474-5548 Negative Studies in the Literature: Summary of Selected Discussions of Negative Studies in Medical Publications
- 87655549 24
- 87655550-5616 An Epidemiological Review of the Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa / 600/6-90/00064 - External Review Draft
- 87655617 25
- 87655618-5642 Comments the Epa Review Draft: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655643
- 87655644-5646 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume III
- 87655648-5684 the Role of Confounding Factors in Assessing Epidemiological Evidence on Ets and Risk of Lung Cancer Comments on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa/600/6-90/006a)
- 87655686-5711 Comment on Dr.Hirayama's Record Linkage Study of Japanese Adults in 'epidemiological Evidence of Lung Cancer From Ets' Chapter 3 of the Epa Review Draft 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655713-5750 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children' A Commentary on Issues Relating to Lung Cancer in the 900500 Epa External Review Draft
- 87655751-5976 A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke (Ets) to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked Text Draft 3
- 87655977-6043 A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke (Ets) to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked Tables Draft 3
- 87656044-6091 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 87656093-6095 United States Environmental Protection Agency Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume IV
- 87656097-6104 Comments by George B. Leslie, Frc Path., on 900500 Epa External Review Draft: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children'.
- 87656106-6172 Summary of Major Criticisms of Epa's Draft Risk Assessment: Health Effects of Passive Smoking
- 87656174-6178 Comments on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Epa/6000/6-90-006a 900500 External Review Draft
- 87656180-6200 Commentary 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87656202-6228 'comments on Draft Usepa Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' (900928)
- 87656230-6263 A Response to the Epa Review Draft Document Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656265-6288 Evaluation of the Epa Draft Report Health Effects of Passive Smoking: Assessment of Lung Cancer and Respiratory Disorders in Children
- 87656290-6301 Review of Epa Draft Document: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656303-6309 Comments on Document Review Draft Epa/600/6-90/006a Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656311-6318 Statistical Evaluation of the Association Between Environmental Tobacco Smoke (Ets) and Health Risks Comments to the Epa Review Draft: Health Effects of Passive Smoking . . .
- 87656320-6356 Comments on the Epa Draft Report on Health Effects of Passive Smoking: Assessment of Lung Function in Adults and Respiratory Disorders in Children
- 87656358-6366
- 87656368-6397 Submission of Comments on the Draft Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656399-6449 Evaluation of A Report by the U.S. Environmental Protection Agency on: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656450-6460 the Confounding of Occupation and Smoking and Its Consequences
- 87656461-6476 Comparison of Risk of Chronic Conditions and Cancer Between Homemakers and Otherwise Employed Women
- 87656481-6483 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume V
- 87656485-6492 Comments on the Epa Review Draft Health Effects of Passive Smoking
- 87656494-6574 Review of the Draft Epa Document Entitled 'health Effects of Passive Smoking, Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656576-6661 Executive Summary Lung Cancer and Exposure to Environmental Tobacco Smoke Assessment of Issues Raised in the Review Draft of the Environmental Protection Agency of the United States
- 87656662-6728 Lung Cancer and Exposure to Environmental Tobacco Smoke Appendix 1 Review of Individual Studies
- 87656729 Lung Cancer and Exposure to Environmental Tobacco Smoke Appendix 2 Papers Submitted for Publication - Not to Be Quoted Without Permission
- 87656730-6748 Confounding and Misclassification Effects in Case Control Studies of Lung Cancer Incidence
- 87656749-6768 Dose-Response Relationships in Studies of Lung Cancer and Exposure to Environmental Tobacco Smoke
- 87656769-6781 Age-Adjustments in Passive Smoking Studies
- 87656783-6796 Comments on the Epa Draft Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656798-6820 Comments on the Draft Environmental Protection Agency Document: 'health Effect of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- Author (Organization)
- Seminars in Respiratory Medicine
- Litigation
- Stmn/Produced
- Characteristic
- EXTR, EXTRA
- UCSF Legacy ID
- cce40e00
Document Images
SEMINARS IN RESPIRATORY MEDICINE-VOLUME 10, NUMBER 4 OCTOBER 1989
Physical, Chemical, and Biologic Properties
of Tobacco, Cigarette Smoke, and Other Tobacco
Products
Gary L. Huber, M.D.
.
The commercial tobacco cigarette of today is a
blend of different tobaccos with a number of addi-
tives; as such, it is a continually changing product.
Since this cigarette is very different from the ciga-
rette that was smoked when the epidemiologic
studies linking smoking to lung and cardiovascular
disease were first reported, comparative assessments
of potential health effects from the currently con-
sumed commercial product are difficult to develop.
It is important, however, to understand the changes
that have occurred in cigarette manufacturing, and
their potential health implications in the present and
the future for the pathogenesis of pulmonary dis-
eases and cardiovascular diseases. The primary
purpose of this contribution therefore is to review
some of the physical, chemical, and biologic prop-
erties of tobacco cigarettes and other tobacco prod-
ucts. Within the scope allowable, this review cannot
be comprehensive. More detailed analyses are pre-
sented in several of the reports by the Surgeon
General on smoking and health," as well as in other
specific contributions that will be cited within this
text. Any attempt to review the properties of the
tobacco cigarette and other tobacco products is a
formidabk undertaking. The literature available is
voluminous, is at times very technical, and is often
beyond the grasp of all but the experienced tobacco
cfiemist.
Is it important for the practicing physician or
pulmonologist to understand something about the
physical, chemical, and biologic properties of the
tobacco cigarette? The answer is "yes," for tobacco
and the tobacco cigarette are much misunderstood
and often misrepresented. Although the literature
that is available is extensive, many of the answers
sought still remain elusive. The information that now
exists is too often inconsistent or, worse yet, contra-
dictoty. Yet, better knowledge is the crucial key to
clarifying still existing controversies on tobacco and
health, to understanding the potential relationship
of tobacco to certain diseases, and, within the
appropriate framework, to developing smoking ces-
sation strategies. This is particularly true for those
components of tobacco products that influence hu-
man behavior. An understanding of the physical,
chemical, and biological properties of the tobacco
cigarette also is essential to assimilating and under-
standing the continually appearing publications on
tobacco and health and on smoking cessation, as well
as to designing and implementing research and
educational programs in related endeavors. An
additional fcxus of this review, then, will be directed
toward clarifying general misrepresentations of the
tobacco product and improving our understanding
of the important related issues.
Finally, it must be emphasized that the lay public
is frequently exposed through a multitude of media
to information about tobacco use and cigarette
smoking. From this exposure, a variety of attitudes,
opinions, awareness, and the like have developed.
Public beliefs are based on public knowledge, and
from these eventually come public policies. Un-
fortunately, not all of the information on tobacco and
health that has been conveyed over these past 35
years of intense interest in and concern for the health
consequences of smoking has been accurate. There
are, after all, two sides to this issue that have been
developed in a continued and consistent manner for
now well over a third of a century. Our knowledge
about many important issues is far from compkte,
some of the inaccuracies probably will never be fully
clarified, and controversy is still sustained because
Univenity of Texas Health Center at Tyler. Tyler. Texas
Reprint requests: Dr. Huber, Department of Medicine. Univernity of rexas, t3mc 4003. Tyler. TX 75710
C19R9 by Thieme McAioi Pubinhcn, tnr., VI Park Avenue Smith. New York. NY 10016. AO riRhts
rsser.tid.
t97

SEMINARS IN RESPIRATORY MEDICINE-VOLUME 10. NO. 4 OCTOBER 1989
some of the disseminated information is not correct.
Even though it was a habit of growing popularity, the
general smoking public had some sense that ciga-
rette smoking was smoething less than a completely
healthy pastime well over half a-century ago. The
saying that tobacco smoking would "impair your
wind" probably dates back, for example, to a study in
school boy track athletes near the turn of the century.
The description of cigarettes as "coffin nails" and the
phrase that tobacco smoking will "stunt your
growth" are at least as old. In the 1950s, according
to the Surgeon General's latest assessment (1989),
the majority of smokers and even more of the lay
public were not aware, however, of many of the
specific health risks associated with smoking; today,
most smokers and most of the general public have a
different perception 6 Relative to the conclusions
recently issued by the office of the Surgeon General,
however, the public still significantly ntisconceivrs or
inadequately understands many of the potential
effects of prolonged tobacco use.'
This contribution is extensively referenced for
several reasons. Many questions about the physical
properties and chemicaF nature of the tobacco
product still remain unanswered or are controver-
sial; references are provided therefore either in
support of the conclusions that are presented or as
a "road map," of sorts, for those who wish to pursue
these considerations in greater depth. Perhaps of
equal importance, this is a time, more than ever
before, in the history of tobacco and health when
public policies on smoking and tobacco use are being
established widely in our society. These changes are
occurring both within the world of medicine and, to
a greater extent, within the broader arena of general
public health. This text and its citations, it is hoped,
will provide an objective review and balanced frame-
work for an understanding of tobacco products that
will be useful and helpful to the establishment of
improved and more responsible policies.
TOBACCO
7daACQO AND 7n8ACCO PRODUCTS
Tobacco is a member of the nightshade family,
it is an important agricultural crop in many parts of
the world, and it is used by httmans in almost every
country. There are as many as 65 or more varying
types of tobacco. All are members of the genus
Nicotiana; variants most commonly grown for com-
mercial use include primarily Nicoeiana fabncum and,
in China, India, and the USSR. Necotierea rustica.
Bright or Virginia (flue cured), burley (air cured),
298 Maryland, oriental (Turkish or aromatic), and cigar
tobaccos are the main variants used in tobacco
products manufactured in the United States. Most
oriental tobaccos are imported. The chemical con-
stituents of these tobacco variants differ from each
other from year to year and are influenced by
growing conditinns, weather, genetic plant variety,
agriculture additives or alterations, regional cultur-
ing practices, curing, and commercial processing. In-
general, however, there are no qualitative differ-
ences as a function of these variables and specific
tobacco components cannot be completely delted
from the plant by selection of agronomic conditions.
The individual chemicals that compose the
tobacco leaf include carbohydrates (glucose, pectins,
cellulose, and several others), lignin, nonfatty or-
ganic acids (malic, oxalic, citric, and others), nitro-
gen-containing -compounds, resins, and several
thousand other ingredients present at extremely low
levels."''I-he carbohydrates and related compounds
are the primary component of the leaf (about 50% of
the weight), along with the tobacco proteins. The
major nitrogen-containing compounds are nicotine
and other alkaloids (about 0.5 to 5% of the leaf
weight), and the tobacco proteins. Other significant
constituents of the unburned tobacco include, by
weighi, the terpens (0.1 to 3.046), polyphenols (0.5 to
5.4%), phytosterols (0.1-2.5%.), carboxylic acids (0.1-
0.79F), alkancs, aromatic hydrexarbons (in extremely
low cencentratiuns), aldehydes, lactones, amines,
and other compounds." How the tobacco leaves are
treated following harvest, in part, influences their
composition, particularly their final carbohydrate
and nitrate content. Flue curing Virginia or bright
tobacco in steam-heated barns results in tobacco leaf
with high sugar concentrations and low levels (less
than 0.1%) of nitrate content. The kss complex
process of air curing burley tobacco results in a
tobacco of low sugar and relatively high nitrate
content (5% or so). Sun curing oriental tobacco
produces a product of intermediate sugar content
that is still low in nitrates (kss than 0.5%).
Tobacco, at one period during its growth, is
relatively high in total protein content, but this level
decreases substantially by the time the tobacco is
suitable for harvesting and curing for its eventual use
as a smoking product. Because of the ease with which
this protein-rich plant can be grrnvn, ongoing agri-
cultural research for years has included considera-
tions for converting the tobacco crop for cigarettes to
one of tobacco prc*ein for f xxl pmdttction." When
the protein kvel is high in the tobacco plant, the
protein-free tobacco residue is, according to con-
sumer and other test panels, totally unsuitable for
smoking; by the time the protein-free tobacco resi-
due is acceptable as a smoking product, the level of
protein is so low that its isolation is economically
unattractive.

PROPERTIES OF TOBACCO- Huse.
The curing of the harvested tobacco occurs
either in dry air or in a Oue-heated environment.
Much of the desired taste and aroma are imparted to
the tobacco during the essential process of curing.
The associated chemical changes predominantly
involve hydrolytic enzymes. The curing process also
incorporates reactions that create compounds not
present, as such, in the growing plant. Most tobacco
is cured in small tobacco barns by the farmer who
grew it. As an alternative, the Department of Agri-
culture has developed a curing process utilizing a
homogenized tobacco slurry instead ofthe harvested
whole kaf.
Once fully cured, tobacco is still not in a form
acceptable for use by_ the consumer. -Ilie cureci
tobacco must be aged. Aging improves aroma and
other properties desirable to smokers. The chemical
processes among the many other_changes of aging
decrease alpha-aminonitrogen and increase volatile
acids. The aging process may take 1, 2, or more years
and it is usually carried out in sealcd barrcls in
warehouses maintained by the cigarette manulac-
turing industry. In addition to curing and aging,
cigar tobaccos are fermented. In this fermentation
process, organic acids are reduced or eliminated by
oxidation and decarboxylation, making the smoke
from cigar tobacco more alkaline relative to the more
acidic smoke generated-from cigarette tobaccos.
The final commercial cigarette product sold in
the United States, as well as in Japan and most
European countries, is usually a blend of burley,
Virginia, Maryland, and oriental leaf tobaccos, as
well as some reconstituted tobacco sheet. Tobacco
cigarettes in the United Kingdom and in Finland are
almost exclusively blends of bright tobaccos. In
France, in parts of Italy, in South America, and in
North Africa, some of the cigarettes marketed com-
prise burley tobaccos. The common practice today of
including ribs and stems of the tobacco plant, as well
as more burley tobacco in the final commercial
bknds has increased the nitrate content of the
American cigarettes, with a concurrent reduction in
deliveries of "ur," including phenols and polynu-
dear aromatic hydrocarbons. An important rise in
nitrate content, with the associated increase in
nitrogen oxides on pyrolytic degradation, has in-
creased the potential for N-nitrosamine formation.'s
The tobacco blends are treated with casing
solutions. These usually include sugars, syrups,
balsams, licorice, and other substances. Retention of
moisture and the associated qualities that contribute
to flavor are maintained by the addition of hu-
mectants to the blend. flavor-enhancing additives,
the subject of recent controversy related to their
potential health effects, are also a part of the final
product; exempting menthol, these in total con-
stitute less than 0.3% of the weight of the tobacco
filler. As "tar" and nicotine deliveries have been
reduced, additional amounts of flavorant have been
added in order to keep the products consumer-
acceptable. The nature and quantity of flavorants
added to cigarettes are trade secrets and, as such,
have not been studied much outside of the tobacco
industry. Flavorants are derived from extracts of
tobacco plants and from other sources, whichinclude
methold oils, fruit extracts, and other flavorful
substances.16 The concern about tlavorings, casings,
and humectants is that, when heated during the
smoking process, they may contribute potentially
harmful by-products to the inhaled materials, or
so-called strangers in the smoke that might be
harmful to human consumers.
At the time of the first report on the health
consequences of smoking, about 16% of the domestic
cigarette market consisted of menthol-flavored
products." Today, that has nearly doubled and for
tlle past decade has leveled off at about 28 to 29% of
the total commercial markct."' Up to 15 mg of
methol are added to each menthol-flavored ciga-
rette.'° Many smokers perceive menthol as providing
a sense of "cooling" and it has been postulated that
this promotes deeper inhalation. Three of every four
black smokers use menthol-ilavored cigarettes, com-
pared with only one of four white smokers,'"""
prompting some to offer this as an explanation for
one of potential multiple reasons why some black
populations appear to have higher mortality rates
for certain smoking-associated diseases;!" a far more
reasonable explanation is that blacks do not have as
many "environmentally clean" jobs as do whites and
thus are exposed to an additional burden of po-
tentially toxic or harmful substances.
Tobacco cigarettes are physically wrapped with
paper. These cigarette papers can be manufactured
with additives, as well, and can be developed with
varying porosity. The porosity of the paper in-
Ouences the burning characteristics of the cigarette
and the nature of the delivered smoke. Increasing
the porosity of the wrapping paper reduces the "tar"
delivered, as well as the levels of such potential
cytotoxins as acetaldehyde, acrolein, furmaldehyde,
and hydrogen cyanide. Increasing the porosity also
reduces the amount of carbon monoxide delivered.
Decreasing the porosity of the wrapping paper has
just the opposite effect.
Filters were introduced on tobacco cigarettes in
the early 1950s. I n 1951, kss than 196 of commercial
cigarettes purchased were filtered. Most, but not all,
cigarettes sold in this country today are filtered; only
a very few percent of the market comprise non-
filtered products. The filters are of many types. Most
of these are cellulose acetate filters, but they also
include charcoal filters, specially bafiled filters, men-
tholated filters, and other kinds. Filtering the to- 299 -

SEMINARS IN RFSI'IRA'IY)RV MF.t)It:INF.-V()LUMt: Itl, N(). 4 (:7Y)BF,R 1989
bacco smoke reduces the delivery of mainstream
total particulate matter and, ofcourse, its component
parts, "tar" and nicotine. This can be achieved
mechanically by reducing the total particulate deliv-
ery by direct filtration. Adding charcoal to the filters
may reduce certain potentially toxic gas-phase com-
ponents, including volatile aldehydes and hydrogen
cyanide, at least as evaluated by some experimental
bioassays. Adsorptive additives incorporated in cel-
lulose acetate filters, which are the most commonly
used filters, potentially can reduce the volatile
nitrosamines, as well as the acidic components of
smoke, including the volatile phenols; magnesium
silicates potentially can diminish the delivery of
organic vapors, stxh as the aldehydes. In addition to
direct mechanical filtration, the filter, or for that
matter the cigarette wrapping paper as well, can be
perforated to introduce air by a Venture-like dilu-
tion: this can also be achieved, at least theoretically,
with longitudinal grcoves in the filter. Air dilution
reduces the delivery of both particulate- phase and
gas-phase components.""
A burning cigarette has been described by many
as "a miniature chemical factory," which produces
multitudes of new components from its basic raw
materials. The first analysis of tohacco smoke was
performed in the mid-1 R(IOs, a few were undertaken
in the late 1920s, and amodest number completed in
the 1930s. By 1954, about 100 tobacco smoke
components had been identified." From that date,
additional components were identified-about 450
by 1959," approximately 950 by 196R,'S and nearly
4000 by 1982.M By some estimates. it has been
suggested that as many as 40,000 or so chemical
entities are present in tobacco smoke. Most of these
are present in only very small trace amounts, and
some are reactive products of the unstable combus-
tion product, making an ultimate quantification very
difficult. In fact, most of the components as yet
unidentified in mainstream cigarette smoke are
present at levels of subnanogram quantities per
cigarette, that is, at levels of picogram per cigarette
or femtogram per cigarette. The levels of most of the
components in mainstream cigarette smoke of con-
cern are in the microgram per cigarette or nano-
gram per cigarette range. Only a few of the compo-
nents, such as prbon monoxide and nicotine, are
present in quantities of milligrams per cigarette.
The processed but unpyrolized tobacco product
contains about 2500 or mote known constituents:"
and varies as a function of many parameten, includ-
ing local growing conditions and what the tobacco
farmer might add to the soil or apply to the growing
plant- Pesticides, fertilizers, and other agricultural
agents used in tobacco farming become incorpo-
rated into the tobacco kaf.='=" l.ess than 20% of the
300 pesticides and other agricultural products incor-
porated into the growing tobacco plant are trans-
ferred to mainstream smoke during the smoking
process. For tobacco harvested from some areas of
the country, government approved agricultural sub-
stances may add at least another 400 or more
chemical species to the already complex cigarette
smoke. In most commercial cigarettes, a few parts
per million of DDT, DDD, and maleic hydrazide may
appear in the mainstream smoke. In general, how-
ever, there has been a trend toward overall reduc-
tion in the pesticides and agricultural chemicals
incorporated into tobacco and delivered in tobacco
smoke.
THE IGNITED CIGARETTE
When a cigarette is smoked, the hydrogen-
supported, oxygen-free burning cone pyrolyzes dur-
ing puffing at a temperature of about 860 to 900°C;!°
between pu(Ts, the smoldering temperatue is about
500 to fi00°(;.z" Approximately 50% of the pyrolyzed
product is generated as neutral to alkaline side-
stream smoke, which for the most part is released to
the environment during smoldering between the ten
or more pu(Ts of a full cigarette; a small amount of
this sidestream smoke is drawn into each inhaled
pull by the smoker. 'llre remainder of the smoke,
exclusive of an amount that is lost to the condensate
that forms downstream along the tobacco cigarette
rod, is generated when air is drawn across the fire
cone by puffing; this smoke traverses through the
butt end of the ciqarette to be inhaled by the smoker
as weakly acidic mainstream smoke. The tempe-
rature of mainstream smoke leaving the cigarette
usually is about 30 to 50'G or even slightly higher.
Much of the condensate produced along the
~
tobacco rod is rcpyrrrlyzcd and/or evaporatcs into
the mainstream smoke as burning progresses down
the length of the cigarette, delivering what some
have considered to be progressively increasing
amounts of potentially bioactive components with
each subsequent pufi; there are other data in the
literature, however, to indicate that the specific
activity of the smoke in a given bioassay is essential
the same for early and late puffs'0 Some compounds
are eluted from the cigarette rod as the smoke is
drawn through it. The concept of relative tobacco
smoke toxicity, appropriately or not, has been based,
in part, on specific tumorigenicity in mouse skin-
painting binassays. In the National Cancer Institute
Tobacco Working Group, for instance, a cigarette
whose delivery was 2 mg of "tar" per cigarette was
considered no "safer" than a cigarette whose "tar"
delivery was 15 mg per cigarette if the "tars" from the
two cigarettes gave the same specific tumorigcnicity
in mouse skin-painting studies. As a cigarette is

PROPER7'IES OF 7-OBACCO- Hvera
smoked, the amount of "tar" does increase in
successive puffs, but the benzoa pyrene to "tar" ratio,
for example, remains the same.
Regardless of its distribution (sidestream or
mainstream), tobacco smoke is an aerosol compris-
ing liquid particles (the so-called particulate phase)
dispersed in a gas (the so-called gas or vapor phase).
There are about 2 to 5 billion panicles in the aerosol
per millileter of tobacco smoke.s' The particles are
electrically charged by a process termed "chemioni-
zation," which in itself may have potential biologic
significance." About 10% or less of the total smoke
wieght is in the monodispersed aerosol particles, and
90% or greater is in the gas vapor.
Some of the tobacco leaf components, such as
nicotine, phytosterols, and long-chained paraffins,
are transferred to some degree to mainstream and
sidestream smoke structurally intact. 1-1te extreme
temperatures and reducing atmosphere provided by
the fire cone result in pyrogcncsis ol a large mtntlxr
of components not originally present in the tobacco
kaf. Most of the nontobacco components in tobacco
smoke, such as the polynuclear aromatic hydro-
carbons, phenols, volatile nitrosamines, and others,
are not actually generated at the fire cone but are
generated in a"cylinder" a lew millimeters in length
situated in the tobaccri rod a few millimeters in fronl
of the first cone and tobacco rod interface, where the
temperature range within the "cylindcr" is 40(1° to
700°C. The major components of smoke that are
generated within the fire cone itself are products of
almost complete comhustion and include water,
ammonia, carbon monoxide, carbon dioxide, nitric
oxide, and the like." Other constituents of main-
stream smoke that are entirely pyrnsynthesved
include benzene and benzo a pyrene. Certain volatile
aldehydes and nitrosonornicotines are partially py-
rosynthesized and partially transferred intact with-
out pyrosynthesization.s`''s
If nicotine delivery is the primary key to con-
sumer gratification and acceptance of the commer-
cial cigarette, there are probably absolute limits on
reduction of "tar" delivery. In an acidic mainstream
smoke, nicotine is delivered for the most part as
protonated nicotine within the aerosol particles, and
the size of that aerosol particle and the solubility of
nicotine limit the quantity of nicotine containable in
individual aerosol particles; in acidic smoke, there
are only very small amounts of free nicotine in the
gas phase. This principle of "solubility" is applicable
to any smoke components found primarily in the
particulate phase. Within the aerosol particle, pro-
tonated nicotine is the singk most plentiful organic
components in the particulate, indeed to the degree
that it may be asked if protonated nicotine is the
solvent or the solute? The optimal ratio of nicotine to
Table t. Oistribvtion of Mainstnant timoke
Total mainstream smoke SOp
Wet total particulate mstler 22
Nicotine 1 3
WaIer 3.7
"Tar" 17
Aerosol gas phase 478
Water 50
Air components 350
Carbon monoxide 20
Carbon dioxide SO
Other components 8
Atl date expressed in mittiprams tor . 500 mp deliverz ciqareee,
es determined by Federal Trade Commission criteria. r
"tar" is about 1:10 or slightly less. As "tar" delivery
from the commercial cigarette was reduced in a
prrtgressivc, stepwise manncr after the early 1 950s,
it was paralleled by an equivalent reduction in the
nicotine delivery. 'lhis reduction was implemented
very gradually, in part because consumers of a given
brand usually do no( tolerate significant detectable
alterations without changing to a different cigarette.
Because nicrrtine-dependent smr>kers appear to re-
quite a finite minimal amount ol nicotine per day, or
per cigarette for that matter, the relative ratio of
nicritine to "tar" has drifted slightl) upward in recent
years. l'his has been brnught about either as a result
of altered tobacco blending or by other manipula-
tions of the processed cigareue, especially as "tar"
delivery has been reduced to ultralow levels in some
commercial cigarettes.
..T".,
lhe particles in the particulate phase of the 400
to 500 mg of aerosol comprising the mainstream
smoke have a relative uniform size distribution of
about 0.2 to 0.4 m mass median diameter, or 0.1 to
1.0 m absolute diameter n This size is fully respir-
able, with most such particles being able to reach the
alveolar spaces. Tbe aerosol is both chemically and
physically unstable, and the particle size grows by
agglomeration as individual aerosol nuclei combine.
About 80% of the smoke of the total mainstream
smoke from a full-flavor cigarette consists of the
components of air drawn into the cigarette during
the putT.'I'he gross distribution ofentities within the
mainstream of smoke are summarized in '1-able I.
The "tar" in this representative example, as mea-
sured by the Federal Trade Commission (FTC)
criteria, contains about 4000 identified smoke com-
ponents. The bulk of the water delivered in main-
stream smoke is that which was drawn through the
I
S01

SEMINARS IN RESPIRATORY MEDICINE-VOLUME 10, NO. 4 OCTOBER 1989
cigarette from the surrounding environment during
the puffs. The "air components" include nitrogen,
oxygen, argon, and the other components normally
present in environmental air. The "other compo-
nents" in the gas phase, summarized in Table 1, are
usually called the "cigarette mainstream vapor or gas
phase," and it contains about 500 now accepted
identified smoke components.
The FTC utilizes the term "tar" in referring,
indirectly, to the total particulate matter generated
by smoking an appropriately preconditioned ciga-
rette in a standard mechanical way, usually to a given
butt kngth or, in some studies, in reference to a
predetermined specific number of standard puffs."
The standard -FTC procedure requires that the
cigarettes be smoked by analysis in a mechanical
device that generates 35 ml puffs of 2 seconds'
duration, at the rate of one puff per minute at 25*C
and 60% relative humidity to a specified butt length.
Eight or ten such puffs of 35 ml at 60% relative
humidity contain substantial levels of water, com--
pared with the weight of FTC "tar" and gas phase
components. The total particulate matter, as a
gravimetric expression, is obtained by passing the
whole mainstream smoke through an absolute Cam-
bridge-type or glass fiber filter (trapping all particles
more than 0.1 m in size) and weighing the collected
particulate matter. The FTC requires cigarette man-
ufacturers to list "tar" delivery (as well as nicotine
content) in advertising their commercial products.
The measurement of "tar" has been variable and, at
times, fraught with controversy. ln 1982, the FTC
introduced modifications for mrasiirement in hopes
of standardizing testing pnxcdures."
appearance. There are "tars" that humans consume
that are derived from many substances other than
the burning of tobacco leaf. A number of in-
vestigators have reported that components present
in "tar," regardless of source, generated under a
variety of laboratory conditions have the potential to
act as tumor initiators, as complete carcinogens, as
cocarcinogens, or as pncer-promoting agents, as
well as inhibitors of cancer or anticarcinogens.s'-"
Eventually, criteria for potential carcinogenicity
were established by international standards." Che-
mical analyses of tobacco smoke reported in the
literature are derived from smoke generated under
standardized laboratory conditions and may not
reflect what the smoker generates under physiologic
conditions."" Some of the more important compo-
nents in the particulate matter of tobacco smoke are
listed in Table 2."
Much -of the early biohazard research on to-
bacco focused primarily on these biologically active -
agents in the "tar" or cigarette smoke condensates, to
the exclusive of potentially equally bioactive gas-
phase components. As a result, the primary emphasis
of the past three decades or so, both in the United
States and abroad, has been to reduce the delivery of
"tar" in the smoked product. and thus theoretically
to reduce the potential carcinogenicity of tobacco
smoke."" The average sales-weighted "tar" deliv-
ery at the end of World War II or thereabouts was
approximately 45 mg per cigarette and 2.5 mg of
nicotine.'" With the introduction of consumer- ac-
ceptable filters, "tar" delivery had fallen to about 35
mg per cigarette in the late 1950s. This has been
reduced in a progressively stepwise manner since the
earliest skin-painting studies linking "tar" carcino-
DEFINITION OF "TAR"
The word "tar" is often written in quotations
because there are differing definitions for its use.
The FTC, as well as most of the scientific community,
use the word "tar" to express the dry weight of the
collected condensate (total particulate matter minus
all water) minus the weight of any nicotine present.
Tobacco chemists, on the other hand, sometimes
refer to "tar" as a laboratory product obtained by
passing cigarette smoke through a cold trap at an
extremely low temperature. Thus, the assertion that
"tar" is inhaled by human smokers is somewhat
misleading; smokers inhale tobacco smoke actually
an an aerosol of particulate matter suspended in a
gas or vapor phase, and not as "tar" in the true senses
of the word.
The laboratory condensate of tobacco smoke is
Table t=ome Intportant Cotnponents In ParftAa/e
Mdte+ el =tnoke
Nicdine Neophyladfriss
Nornioolinw t3lyoera
An.fabine Lknprwrw
An.basine PanNic Wld
eivrr+dya Sts.rtc .do
n-Hentri.corN.ne 9w+c aad
NaptNMlene tJnotefc acid
Phsnuwnrens LMroNnic acid
Annxaoenes Lacfic tteid
Fkarenes tndote
Prerms Skatae QD
Ftuwamnnes Ouinolinss ~
Olher polynuckar arornNic 8snzoturans ~
~~~ a
sUoaera CA
C.lechol C.mpeqerol rA
8aopaetin Cho4stera - rA
Cyctotsr,es AflNifN
A
IP
o{/tf10wlf Tauidinet
so4nssa N-Nilros~min"
tieet+t.w
referred to as "tar" because of its dark, viscous 'Ad.p.d trom r+oem.nn and

PROPERTIES OF TOBACCO- Huset
gens to cancer in skin-painting experimental ani-
mals; the present "tar" delivery, based on sales-
weighted averages, is about 13 mg per cigarette.
"TAR REDUCTION"
'Tar" delivery from a cigarette is influenced by
the tobacco blend, kaf thickness, cut width, rate of
leaf burn, moisture content, packing density, use of
reconstituted tobacco sheets or expanded tobacco,
and the properties of the filter tip. Burning rate, as
well as dilution of the smoke generated, are influ-
enced, in turn, by the porosity and characteristics of
the cigarette paper, as well as by other factors.
Reductions in "tar" delivery much below 15 mg per
cigarette requires, in addition to mechanical filtra-
tion, Venturi air dilution, either through the ciga-
rette paper or via entry of air into the f lter. Absolute
mechanical filtration reduces particulates without
necessarily reducing the levels of gas-phase compo-
nents; air dilution, on the other hand, reduces the
levels of both particulate-phase and gas-phase com-
ponents. -
The "tar" reductions in consumer-acceptable
filter-tip cigarettes were accomplished only in part
by the filter tip. The first successful tlter-tip ciga-
rette, introduced in late 1953, incorporated not only
the cellulose acetate filter tip but also substantial
levels of a proprietary reconstructed tobacco sheet.
By 1960, all of the other cigarette manufacturers in
the United States had-introduced filter-tip brands
and were including in their blends their own pro-
prietary reconstituted tobacco sheets. By the late
1950s, higher porosity cigarette papers were also in
use. Thus, filtration alone was not the sole design
factor in lowering "tar" delivery. Because of the
introduction in reconstituted tobacco leaf and po-
rous paper, "tar" delivery from nonfiltered ciga-
rettes was also reduced during this time period.
Although the definition of "tar" is somewhat
arbitrary, The FTC has accepted it for classifying and
reporting cigarette total dry nicotine-free particulate
delivery. The definition of "tar," that is, the weight
of "tar" equals the weight of the total wet particulate
water minus the weight of the water and nicotine
present, is the one now issued by the FTC and used
in the United States. Thus, high "tar" cigarettes are
designated as those delivering greater than 15 mg of
"tar" under standard smoking conditions. [.ow "tar"
cigarettes are those that deliver 15 mg or kss, but
greater than 5 mg, and ultralow "tar" cigarettes are
those delivering 5 mg or less of"tar." The delivery of
smoke or total particulate matter under "standard
smoking conditions" with a mechanical smoking
machine may or may not be representative of how
much "tar" or total particulate matter is actually
delivered to the lungs of a human smoker, depend-
ing on a large number of variables.
Although it has been widely accepted that
reducing "tar" delivery will reduce eventually the
rate of lung cancer and other discases associated with
smoking, the validity of that assumption can be
questioned. If, for instance, people smoke primarily
for the nicotine in tobacco cigarettes, and if nicotine
is reduced in direct relationship to "tar," there is a
suggestion in some studies that smokers will smoke
each low or ultralow "tar" cigarette differently, or
smoke more low or ultralow "tar" cigarettes in an
effort to meet their nicotine needs. Research on
smoking behavior, however, is extremely complex,
and complicated by many uncontrollable variables.
Thus, the "evidence" that individuals "titrate" or
"accommodate" their smoking behavior as a func-
tion of nicotine delivery is weak, inconsistent, and
controverted. If they were to do so, such changes in
smoking behavior might result in a higher exposure
to gas-phase components than would have occurred
with a higher nicotine to "tar" delivery ratio. By
using carbon monoxide as an indicator of gas-phase
exposure, some studies indicate higher carboxyhe-
moglobin levels in smokers using low "tar" ciga-
rettes; other studies do not, however, confirm this. l f,
relative to exposure tn "tar," the gas phase is
independently bioactive, it has been hypothesized
that a person may simply be exchanging one disease
risk relationship (cardiovascular disease and carbon
monoxide, as a theoretical example) for another
(lung cancer and "tar") as net or total "tar" reduction
occurs;'° this hypothesis, however, has not been
supported or borne out by clinical or epidemiologic
data.
NICOTINE
The primary ingredient in tobacco that makes it
uniquely desired by the consumer is nicotine. By
chemical structure, nicotine is an alkaloid tertiary
amine that is composed of a pyridine and pyrolidine
ring. There are two possible stereoisomers of nico-
tine. Nearly all of the nicotine in tobacco is the
pharmacologically active isomer, (S)-nicotine (or
levo-nicotine, by some notations). During the smok-
ing process, some of the (S)-nicotine is converted to
(R)-nicotine (or dextronicotine), which is much kss
pharmacologically active than the (S)-isomer.'OAbout
90% of the nicotine in smoke is (S)-nicotine.'Onere
are additional alkaloids in tobacco other than nico-
tine, most of which are 3-pyridyl derivatives. These
include nornicotine, myosmine, anabasine, nicoty-
rine, and anatabine, as well as others, accounting in
total for about 10%, more or less, of total alkaloids.w
w'lhese minor tobacco alkaloids have less phar-
macologic and biologic importance. 303

Sf:MINARS IN RFSI'IRA'I()RV MF:I11(;INN-V(1L.tlMF: 1(1, N(1. 4(N;7OR/i!t 19R9
In the tobacco plant, the bulk (75 to 95%) of the
nicotine is found primarily in the laminae; the
remainder is found in the leaf midrib stems or main
plant swlk.'-" For flue-cured tobacco, the stem nic-
otine to leaf nicotine ratio is about 0.24. For burley
tobacco, the ratio is lower, at atx)ut 0. 17. ne tobacco
plant stalk represents about 25% of the total tobacco
plant weight. The-weight of the main stems in the
leaves is also about 25% of the weight of the tobacco
plant. Leaves high on the plant generally contain
more nicotine than lower leaves.s`
Ahead of the burning cone of the tobacco
cigarette, nicotine is vaporized during the puff and
is transported toward the mcwth end of the ciRarctuc.
Vaporized components of tobacco smoke, such as
nicotine, are cooled en route through the tobacco
rod and participate in the formation of the liquid
droplets in the smoke aerosol. Some nicotine con-
denses downstream on the cooler tobacco rod and is
involved in the same process (vaporization, aerosol
formation, condensation) during each of the sub-
sequent puffs. Some aerosol particles, containing
nicotine, are also filtered from the smoke stream by
the tobacco rod. In most commercial cigarettes, only
about 1-5% of the total nicotine appears in the
mainstream smoke; 25 to 40% is released to side-
stream smoke, and 15 to 25% is deposited within the
butt (and filter tip). The remainder is pyrolyzed to
nicotine decomposition products.
Although it is commonly stated that nicotine is
vaporized," that is not strictly true. Nicotine is
present in tobacco in the protonated form, as salts of
a variety of acids. Dnring exposure to the elevated
temperatures present in the smoking process, the
nicotine salts decompose to nicotine and acid; this
nicotine appears in the smoke stream. Some nicotine
salts at elevated temperature decompose completely
to nicotine plus acid; sonic decompose to nicotine,
acid, nicotine degradation products, and acid de-
gradation products; and, finally, some nicotine salts
decompose completely to nicotine degradation -
products and acid degradation products.
The major pyrolysis pnxlucts of nicotine itsclf
are carbon ntonoxide, cartxon dinxidc, g-vinyl-
pyridine, 3-methylpyridine, pyridine, mysomine,
and 4,3-dipyridine. Some of the characteristics of
smoking, such as the frequency of puffing, may
influence the delivery of nicotine and other alkaloids
to the smoker.s''The presence of the non-nicotine
alkaloids may inQuence the pharmacokgic attiivity
and metabolism of nicrnine `R "` Most of tlte nicotine
in tobacco smoke generated from American ciga-
rettes, as well as most of the cigarettes marketed in
F'inland and the United Kingdom, is carried on or
within the "tar" microdroplets, with only a very small
304 amount of nicotine in the vapor phaseas
ABSORPTION OF NICOTINE
Nicotine is a weak base and the absorption of
nicotine across biologic membrancs depends on its
pH, or state of acid-base dissociation."'The pH of
burning tobacco, in turn, is determined primarily by
its type and composition. A mixture of flue-cured
tobaccos constitutes the major component (30 to
40%) of theblend in most cigarettes manufactured in
tlte United States. When burned, the pH of the
mainstream smoke from these cigarettes is acidic,
..ith the first puffs having a pH of about 6.0 and
subsequent puffs progressively decreasing slightly to
a pH of alxiut 5.0.' In an aqueows milicu, nicotine
has an itxlcxof iomic dissiriatiom or pKa nf ahnut 8.0,
which means that when it is delivered by most
tobacco cigarette smoking. nicotine is almost com-
pletely protonated. Prutonated nicotine does nut
cross biologic membranes in any appreciable
amounts. Thus, almost no nicotine from cigarette
smoke is absnrbed in the mouth, pharynx, or upper
respiratory passaReaays.R' Indeed, in its nonproto-
nated form, inhaled nicotine has an acute toxicity for
man. The unique "advantage" of tobacco cigarette
smoke, then, is that in an acidic state it can deliver the
nicotine-containing microdroplets in a nontoxic
form that will bypass the otherwise operative de-
fenses of the upper respiratnry system. When the
cigarette smoke microdroplets reach the alveolar
spaces and deposit on the vast internal surface of the
IunR. they are immediately buffered to a physiologic
pH of near 7.4. l'his is close enough to the index of
ionic dissociation so that a significant portion (more
than 30% of the total amount) of the nicotine is in a
nonprotonated state and, as such, is rapidly and
efficiently absorbed across the air-bkxxl barriers at
the alveolar surfaces."i Concentrations of nicotine
then increase rapidly in the blood and peak near the
end of the smoking of a cigarette. Depending on
inhalation patterns, retention times, and related
factors, smokers may retain anywhere from 30% or
less up to 9096 or more of the total nicotine generated
and dclivered via the inltaled smokc."
Bratusc the pl I of cigarette ttAr.tcno smoke is
less than 7.0, very little nicotine is absorbed across
the oral mucous membnnes, even if the smoke is
held in the mouth for relatively long peri-
ods."Through a selection of different tobaccos,
however, oral snuffand chewing tobacco are basic, or
have a p1I greater than 7.0, thus rcndcrina their
nicotine mure readily absctrbcd trotn the
mouth!"'a Nicotine polacrilex gum is also buffered
by the manufacture to a pH greater than 7.0 to
facilitate absorption!" Nicotine absorption across
the oral mucous membranes is slower than across the
much more extensive internal surface of the lung.

PROPERTIES OF TOBACCO- Huitr.
Fine ground nasal snuff has nicotine absorption rates
comparable to those in inhaled cigarette smoke.
Nicotine that is swallowed is usually absorbed
very poorly in the stomach because of the gastric
acidity 67 In the alkaline small intestine, however,
nicotine is nonprotonated and readily ab-
sorbed." Nicotine that enters the body via the gas-
trointestinal tract has a diminished net psychotropic
influence because it must first pass via the portal
circulation into the liver, where it is degraded to less
biologically active breakdown products. Nicotine
that enters via the nasal or oral mucous membranes,
or via the lung, passes directly into the systemic
circulation and reaches the central nervous system
relatively intact. Uncommonly, nicotine can be ab-
sorbed across the skin, especially in tc>fmcco field
workers, and potentially reach the systemic circula-
tion in sometimes very high concentrations.'r
Commercial smoking products vary signif-
icantly in the amount ornicotine they potentially can
deliver to the smoker. )n addition, the act of stnokinR
is itself a very ccnnplex behavioral act. '11te smoker
can control the exposure and dosimetry to the
inhaled smoke, including the delivery of nicotine, by
the manner in which the cigarette is smoked.
Usually, this is not a conscious manipulation, and
attempts to quantify delivery by the smoker's own
assessments or perceptions have been generally
grossly inaccurate when evaluated against reliably
quantifiable chemical parameters. Ilie amount of
nicotine that a smoker will extract from a cigarette is
determined by the number of puffs generated, the
volume of each pufT, the rate and depth of smoke
inhalation, the degree that the smoke is diluted by
environmental air, the rate of pufling, the intensity
of pufiing, and the smoke inhalation and exhalation
patterns, as well as other factors"""' Regardless of
the puff volume generated, some smokers barely
inhale at all, often with an amotmt kss than a nortnal
tidal volume. Some smokers inhale larger vulnmes,
by taking a forced expiration just before inhalation,
but stop their inhalations near their functional
residual capacity; others inhale deeply, sometimes to
near residual volume. Some smokers hold their
inhaled smoke only transicntly or rnN at all, whereas
others may hold the inhaled smoke wi:thin thcir
lungs for several seconds. Some exhak only through
their mouth, others only through their nose, and still
others through botlt their mouth and nose. Some
smokers may seal the ventilation ports in the ciga-
rette filters with their lips, and others may seal the
filter parts or paper porosity with their 6ngers.'s All
of these facton change the dosimetry for each
individual smoker and for each cigarette. The way in
which a person smokes, however, generally is re-
markably consistent from cigarette to cigarette,
providing the constituents of the cigarette remain
the same or are altered only slowly and in small
increments. Regardless, the dose of smoke delivered
can be reliably determined only by measuring one or
more of its constituents in the blood."
The range of individual intake of nicotine per
day in smokers can be quite wide. In a limited
number of smokers, several studies have reported
comparable results." """ The intake of nicotine from
each cigarette averaged about 1 mg in one study, but
with a range from well less than 0.5 mg to greater
than 1.5 mg with an average total daily intake of near
40 mg and with wide ranges on each side of the
mean."
FATE OF NICOTINE
In the bkxwdstream, at a pli of approximately
7.4, about two thirds of the nicotine is nonproto-
nated and less than 5% is bound to plasma pro-
teins.'"'° llte lungs, brain, spleen, and liver have a
high aflinity for niccttine; in these tissues it reaches a
cnncentratiom more than twice greater than that
which would be predicted on the basis of measurable
blood concentrations and body weight alone. Adi=
pose and muscle tissue have an apparent very low
affinity for nicotine, and it is not stored within the
body in appreciable amounts or for long periods of
tinte. Nicotine freely crosses the placenta and can be
aspirated from amniotic Ouid.' Nicotine is also
found in saliva," in cervical mucous secretions" and
other tissue fluids, and in body hair."s Nicotine is also
found in nonlactating breast fluids and in breast
milk, but only in very low concentrations.'
Once in the blood, nicotine peak levels are
reduced fairly rapidly. Depending on tlhe urinary
pN, some nicotine is lost via the kidneys, up to 30%
or more in some reFxorts, but more commonly in the
range of 5 to 10% of the total absorbed dosage;41" a
stahlc urinary mctabolue is trans-3'-hydroxy-
cotinine."'lltere is some metabolism of nicotine
within the lung ," bttt for the most part nicotine is
metabolically deactivated by oxidation in the liver."`-
"The major primary stable degradation product is
crninine, which is formed primarily in the liver in two
stcps."s"0 t:cttininc has an average half-life in humans
of alxmt 16 to 20 hours, and much of it is excreted
in the urine. Because of this long half-life, 72-hour
collections of urine are necessary for quantitative
measurements; many studies using shorter collec-
tions have resulted in erroneous conclusions. Coti-
nine levels persist in the bkNid at severalfold higher
levels than nicotine. The other major metabolic is
nicotine-I'-N-0xide. which can be converted by
bacteria (both in vivo and in vitro) to nicotine.""
The half-life of nicotine in the circulation is of
significant interest to studies on smoking behavior
and smoking cessation. The plasma levels of nicotine,

SEMINARS IN RFSPIRAIORti' MF:111(:INF:-VOLUME 1(l, NU. 4 fX;l'f)l31iN 1989
measured in the afierncxon in smokers, arc in the
range of 10 to 50 fig/ml, and generally toward the
lower end of that range."" The incremental in-
crease from smoking one tobacco cigarette is in the
range of 5 to 30 Ng/ml, and the peak and trough
levels oscillate as a function of individual smoking
patterns."'"" Similar blorxl levels are found in pipe
smokers and in the users of snuff, chewing tnhacco,
and other noncigarette products, although the rate
of increase of nicotine into the blood by these
delivery systems is generally slow'µ-6RO°'"= Early re-
ports suggested a-nicotine half-life of fairly short
duration, in the range of 20 to 40 minutes't`" More
went studies more accurately indicate a half-life in
man closer to 2 hours, but with a range of between
I and 4 hours." These longer half-lives imply that in
human smokers the psychoactive component of
tobacco accumulates at probably a slightly progres-
sively higher level throughout the awake petiod and
persists at lower- but still significant levels even
during sleep. I nvohtntary inhalers of environmental
smoke have extremely low levels of nicotine coni-
pared with nicotine levels in voluntary cigarette
smokers and have a slower rate of nicotine elimina-
tion.10'
ACUTE NICOTINE TOXICITY
Acute nicotine intoxication is a well-known
entity. The most common manifestations include
pallor, generalized weakness, nausea, emcsis, light-
headedness or dizziness, headache, and diaphoresis.
Less frequently, chills and vigors, abdominal cramps
or pain, and hypersalivation occur. In severe cases,
hypotension, seizure activity, respiratory arrest, and
death can develop.
Novice smokers generally experience the less
severe of these symptoms, if any, on their firsl
exposure to tobacco. This was perhaps more true in
the past than it is today, however, because of the now
ready availability of the ultralow nicotine delivery
cigarettes, compared with the relatively very high
nicotine delivery cigarettes that were common be-
fore the introduction of filters and air dilution.
Accidental poisoning with nicotine-containing pesti-
cides or suicide attempts with nicotine products have
been reported. "Green tobacco sickness" is an entity
that occurs in farm workers exposed to aqueous
nicotine solutions during the harvesting of rain-
soaked or dew-cnated tobacco leaves.
MEASUREMENTS OF NiCOTJNE AND COTIN/NE
LEVELS
Reliably quantifying nicotine and cotinine levels
in human smokers is not easy. Methods of analy-
sis1O"' and selected references for analysis are
S06 presented in Table 3. The use of gas chromato-
T.bte 3. Methods of Analysis for NIoothte In dtologk
Fluids
Method M/ennoe
Radiodmmunosssay (RIA) 1a-106
Enzyme-Iinked immunoabsorbence (ELISA) 107
Gas chrometopraphy (GC) 108-113
Hiph-perlofinence liquid chromatoprsphy
(HPLC)
114.115
Gas chromsloqraphy-msss spectromeky
(GC-MS)
116-118
graphy and mass spectrometry provides the most
sensitive, speciGc, and reliable analyses, but the cost
of these methodologies prohibits widespread appli-
cation. High-performance liquid chromatography
also has a reasonable sensitivity, but only on such
relatively large amounts of biologic samples that its
use is not readily applicable. Gas chromatography
and radioimmunoassay are probably used most
cOmmrntly hnt are (raught with error in thc hands crf
the inexperienced analyst. Radioimmunoassays are
simple to use, relatively inexpensive, and usually
require small sample volumes; their main shortcom-
ing is lack of specificity, due primarily to antibody
cross-reaction with cotinine and with endogenous
prrxlucts common to human fluids. Gas chromatog-
raphy is more accnrate and reasonably accessible.
but more expensive; use of nitrogen-phosphorus
detectors and high-resolution capillary columns en-
hances accuracy. Chromatographic analyses are also
vulnerable to nicotine contamination from the en-
vironment, including from within the research lab-
oratory."° lhe higher levels of cotinine in the to-
bacco user, its stability as a breakdown product of
nicotine, its longer half-life, and its ease ofquantifica-
tion make it in most ways a more reliable and
desirable product to assay than nicotine. The long
half-life of cotinine, however, does not-make it as
reliable an indicator as nicotine in assessing relatively
acute fluctuations, such as those that occur during
smoking.'=""
People smoke tobacco or use other tobacco
products for the effect that nicotine has on the
central nervous system, where specific nicotine re-
ceptor sites have been identified. The other biologic
effects of nicotine that have been addressed herein
are of a very secondary nature. Through the central Co
nervotts system, and to a lesser extent indirectly ~
thnxtgh peripheral neuroendocrine interactions, ~
the effects of nicotine are perceived generally by the Cn
consumer in a number of different ways that are ,p
considered beneficial. These effects of nicotine on .A
the central nervous system and human behavior are N
reviewed at length elsewhere within this series of
cmntributinns in Snniruns, as are the perceivable
